NASDAQ:CNTB

Connect Biopharma Holdings American Depositary Shares Stock Forecast

etoro logo Buy CNTB
*Your capital is at risk
$2.46
+0.0700 (+2.93%)
At Close: Jul 02, 2026
AI Analysis AI Analysis of CNTB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CNTB to Watchlist?
Some Reasons Why To Add CNTB:
  • +110.4% price growth over the last year
  • High gross margin of 100.0%
  • Lower volatility than the market (beta -0.21)
PDF

Connect Biopharma Holdings Ltd American stock price up 2.93% on Thursday
(Updated on Jul 02, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 29, 2026 Gain 3.36%

The Connect Biopharma Holdings Ltd American stock price gained 2.93% on the last trading day (Thursday, 2nd Jul 2026), rising from $2.39 to $2.46. During the last trading day the stock fluctuated 5.53% from a day low at $2.35 to a day high of $2.48. The price has risen in 6 of the last 10 days and is up by 18.27% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 77 thousand more shares were traded than the day before. In total, 446 thousand shares were bought and sold for approximately $1.10 million.

Given the current short-term trend, the stock is expected to fall -22.80% during the next 3 months and, with a 90% probability hold a price between $1.44 and $1.90 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CNTB Signals & Forecast

The Connect Biopharma Holdings Ltd American stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.28 and $2.25. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 16, 2026, and so far it has risen 23.62%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Connect Biopharma Holdings Ltd American has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for Connect Biopharma Holdings Ltd American stock

Connect Biopharma Holdings Ltd American finds support from accumulated volume at $2.38 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.130 between high and low, or 5.53%. For the last week, the stock has had daily average volatility of 7.97%.

Our recommended stop-loss: $2.37 (-3.60%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 11 days ago.)

Trading Expectations (CNTB) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Connect Biopharma Holdings Limited American Depositary Shares to open at $2.43, and during the day (based on 14 day Average True Range), to move between $2.37 and $2.55, which gives a possible trading interval of +/-$0.180 (+/-7.58%) up or down from last closing price. If Connect Biopharma Holdings Limited American Depositary Shares takes out the full calculated possible swing range there will be an estimated 7.58% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.38 (3.25%) than the resistance at $2.68 (8.94%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Connect Biopharma Holdings Limited American Depositary Shares stock A Buy?

Connect Biopharma Holdings Ltd American holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $2.43 ( 1.22%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CNTB Performance

Trading levels for CNTB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.56 4.07%
R2 2.51 2.05%
R1 2.48 0.799%
Price 2.46
S1 2.38 -3.24%
S2 2.35 -4.49%
S3 2.30 -6.50%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.05 23.98%
R2 2.82 14.63%
R1 2.68 8.94%
Price 2.46
S1 2.38 -3.25%
S2 2.19 -10.98%
S3 1.99 -19.11%

FAQ

What is the symbol for Connect Biopharma Holdings Limited American Depositary Shares Stock and on which exchange is it traded?
The symbol for Connect Biopharma Holdings Limited American Depositary Shares is CNTB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Connect Biopharma Holdings Limited American Depositary Shares Stock?
Connect Biopharma Holdings Ltd American holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Connect Biopharma Holdings Limited American Depositary Shares Stock?
Connect Biopharma Holdings Limited American Depositary Shares Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Connect Biopharma Holdings Limited American Depositary Shares Stock.

What's the current price of Connect Biopharma Holdings Limited American Depositary Shares Stock?
As of the end of day on the Jul 02, 2026, the price of an Connect Biopharma Holdings Limited American Depositary Shares (CNTB) share was $2.46.

What is the 52-week high and low for Connect Biopharma Holdings Limited American Depositary Shares Stock?
The 52-week high for Connect Biopharma Holdings Limited American Depositary Shares Stock is $3.82 and the 52-week low is $1.03.

What is the market capitalization of Connect Biopharma Holdings Limited American Depositary Shares Stock?
As of the Jul 02, 2026, the market capitalization of Connect Biopharma Holdings Limited American Depositary Shares is 154.891M.

When is the next earnings date for Connect Biopharma Holdings Limited American Depositary Shares?
The upcoming earnings date for Connect Biopharma Holdings Limited American Depositary Shares is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT CONNECT BIOPHARMA HOLDINGS LIMITED AMERICAN DEPOSITARY SHARES
Connect Biopharma Holdings American Depositary Shares
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosin...
GOLDEN STAR
Ticker Change Signal Date
B
BXDC
$21.71
1.11% Jun 29
SRPT
$17.02
13.28% Jun 29
OSIS
$218.29
1.59% Jun 26
NMRK
$15.02
4.66% Jun 24
JLL
$299.78
9.23% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE